217 related articles for article (PubMed ID: 28461752)
1. The effectiveness and safety of amisulpride in Chinese patients with schizophrenia who switch from risperidone or olanzapine: a subgroup analysis of the ESCAPE study.
Liang Y; Yu X
Neuropsychiatr Dis Treat; 2017; 13():1163-1173. PubMed ID: 28461752
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of amisulpride in Chinese patients with predominantly negative symptoms of schizophrenia: a subanalysis of the ESCAPE study.
Liang Y; Yu X
Neuropsychiatr Dis Treat; 2017; 13():1703-1712. PubMed ID: 28721051
[TBL] [Abstract][Full Text] [Related]
3. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
Krzystanek M; Krupka-Matuszczyk I
Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
[TBL] [Abstract][Full Text] [Related]
4. Amisulpride versus risperidone in the treatment of depression in patients with schizophrenia: a randomized, open-label, controlled trial.
Kim SW; Shin IS; Kim JM; Lee SH; Lee JH; Yoon BH; Yang SJ; Hwang MY; Yoon JS
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1504-9. PubMed ID: 17692448
[TBL] [Abstract][Full Text] [Related]
5. Early non-response as a predictor of later non-response to antipsychotics in schizophrenia: a randomized trial.
Long Y; Wu Q; Yang Y; Cai J; Xiao J; Liu Z; Xu Y; Chen Y; Huang M; Zhang R; Xu X; Hu J; Liu Z; Liu F; Zheng Y; Meng H; Wang Z; Tang Y; Song X; Chen Y; Wang X; Liu T; Wu X; Fang M; Wan C; Zhao J; Wu R
BMC Med; 2023 Jul; 21(1):263. PubMed ID: 37468932
[TBL] [Abstract][Full Text] [Related]
6. Evidence for the effectiveness of olanzapine among patients nonresponsive and/or intolerant to risperidone.
Dossenbach MR; Kratky P; Schneidman M; Grundy SL; Metcalfe S; Tollefson GD; Belmaker RH
J Clin Psychiatry; 2001; 62 Suppl 2():28-34. PubMed ID: 11232749
[TBL] [Abstract][Full Text] [Related]
7. The effectiveness and safety of amisulpride in Chinese patients with schizophrenia: An 8-week, prospective, open-label, multicenter, single-arm study.
Liang Y; Cao C; Zhu C; Wang C; Zhang C; Dong F; Yang F; Deng H; Yu J; Tang J; Su L; Xin L; Hong L; Gao M; Tang M; Xie S; Lu S; Liu T; Xu X; Wang X; Li X; Wang X; Li Y; Zhang Y; Chen Z; Yu X
Asia Pac Psychiatry; 2016 Sep; 8(3):241-4. PubMed ID: 27020720
[TBL] [Abstract][Full Text] [Related]
8. Relapse in patients with schizophrenia and amisulpride-induced hyperprolactinemia or olanzapine-induced metabolic disturbance after switching to other antipsychotics.
Cai J; Li L; Shao T; Sun M; Wang W; Xie P; Wang X; Yang Y; Long Y; Kang D; Xiao J; Su Y; Peng X; Huang Y; Gao M; Wu Q; Song C; Liu F; Shao P; Ou J; Shen Y; Huang J; Wu R
Psychiatry Res; 2023 Apr; 322():115138. PubMed ID: 36871411
[TBL] [Abstract][Full Text] [Related]
9. Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study.
Kahn RS; Winter van Rossum I; Leucht S; McGuire P; Lewis SW; Leboyer M; Arango C; Dazzan P; Drake R; Heres S; Díaz-Caneja CM; Rujescu D; Weiser M; Galderisi S; Glenthøj B; Eijkemans MJC; Fleischhacker WW; Kapur S; Sommer IE;
Lancet Psychiatry; 2018 Oct; 5(10):797-807. PubMed ID: 30115598
[TBL] [Abstract][Full Text] [Related]
10. An open-label randomised comparison of aripiprazole, olanzapine and risperidone for the acute treatment of first-episode schizophrenia: Eight-week outcomes.
Cheng Z; Yuan Y; Han X; Yang L; Cai S; Yang F; Lu Z; Wang C; Deng H; Zhao J; Xiang Y; Correll CU; Yu X
J Psychopharmacol; 2019 Oct; 33(10):1227-1236. PubMed ID: 31487208
[TBL] [Abstract][Full Text] [Related]
11. Quetiapine versus other atypical antipsychotics for schizophrenia.
Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
[TBL] [Abstract][Full Text] [Related]
12. Amisulpride versus risperidone in the treatment of schizophrenic patients: a double-blind pilot study in Taiwan.
Hwang TJ; Lee SM; Sun HJ; Lin HN; Tsai SJ; Lee YC; Chen YS
J Formos Med Assoc; 2003 Jan; 102(1):30-6. PubMed ID: 12684609
[TBL] [Abstract][Full Text] [Related]
13. Amisulpride: a review of its use in the management of schizophrenia.
McKeage K; Plosker GL
CNS Drugs; 2004; 18(13):933-56. PubMed ID: 15521794
[TBL] [Abstract][Full Text] [Related]
14. Effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone.
Kim KS; Pae CU; Chae JH; Bahk WM; Jun TY; Kim DJ; Dickson RA
J Clin Psychiatry; 2002 May; 63(5):408-13. PubMed ID: 12019665
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
Lindenmayer JP; Eerdekens E; Berry SA; Eerdekens M
J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593
[TBL] [Abstract][Full Text] [Related]
16. Fluphenazine (oral) versus atypical antipsychotics for schizophrenia.
Sampford JR; Sampson S; Li BG; Zhao S; Xia J; Furtado VA
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD010832. PubMed ID: 27370402
[TBL] [Abstract][Full Text] [Related]
17. A pilot study of the safety and efficacy of amisulpride and risperidone in elderly psychotic patients.
Riedel M; Eich FX; Möller HJ
Eur Psychiatry; 2009 Apr; 24(3):149-53. PubMed ID: 19070995
[TBL] [Abstract][Full Text] [Related]
18. Aripiprazole versus other atypical antipsychotics for schizophrenia.
Khanna P; Komossa K; Rummel-Kluge C; Hunger H; Schwarz S; El-Sayeh HG; Leucht S
Cochrane Database Syst Rev; 2013 Feb; (2):CD006569. PubMed ID: 23450570
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of switching to ziprasidone for stable but symptomatic outpatients with schizophrenia.
Weiden PJ; Simpson GM; Potkin SG; O'Sullivan RL
J Clin Psychiatry; 2003 May; 64(5):580-8. PubMed ID: 12755663
[TBL] [Abstract][Full Text] [Related]
20. [Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone].
Bret P; Bonnet F; Bret MC; Jaffré A
Encephale; 2002; 28(4):329-42. PubMed ID: 12232542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
